Ubs Asset Management Americas Inc Ionis Pharmaceuticals Inc Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 320,290 shares of IONS stock, worth $12.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
320,290
Previous 186,327
71.9%
Holding current value
$12.7 Million
Previous $8.08 Million
88.99%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding IONS
# of Institutions
389Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$550 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$502 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$410 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$328 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$261 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.64B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...